Method for treating cancer
US11642349B2 · kind B2 · utility
4Cited by
33References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2020 |
| Grant date | May 9, 2023 |
| Priority date | — |
| Expiry date | Jun 22, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.